AI Prostate Cancer Test Enters Clinical Use in Puerto Rico
The test analyzes digital biopsy images to help predict treatment response and long-term outcomes for patients with localized prostate cancer.
Read MorePosted by CLP Edit Staff | Jul 8, 2026 | Digital Pathology, Prostate |
The test analyzes digital biopsy images to help predict treatment response and long-term outcomes for patients with localized prostate cancer.
Read MorePosted by CLP Edit Staff | Jul 6, 2026 | Colorectal |
A blood test detecting circulating tumor DNA post-surgery can help identify colorectal cancer patients with liver metastases who are most likely to benefit from adjuvant chemotherapy, according to data from the Phase II GALAXY study.
Read MorePosted by CLP Edit Staff | Jul 2, 2026 | Company News, Diagnostic Technologies, Molecular Diagnostics |
The transaction includes subsidiaries in the United States, Sweden, and Australia to expand transplantation diagnostic offerings.
Read MorePosted by CLP Edit Staff | Jul 2, 2026 | Standards |
The recommendations provide a framework for interpreting results affected by hormone therapy and improving electronic health record practices.
Read MorePosted by CLP Edit Staff | Jun 30, 2026 | Cancer, Company News, Womens Health |
The expanded commercialization agreement aims to increase availability of the GlycoKnow Ovarian laboratory-developed test through Aranscia’s clinical workflow and technology platforms.
Read More